Graves' disease accompanied by anti-myeloperoxidase antibody-related nephropathy and autoimmune hepatitis

Internal Medicine

Volumn 43, Issue 6, 2004, Pages 516-520

  Nagai, Takashi ^b   Imamura, Makoto ^b   Kamiya, Yuji ^b   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Public Tomioka General Hospital   (Japan)

Author keywords

Autoimmune hepatitis; Minor glomerular abnormalities; Propylthiouracil

Indexed keywords

LEVOTHYROXINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; COMORBIDITY; FEMALE; GLOMERULOPATHY; GRAVES DISEASE; HEMATURIA; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; KIDNEY BIOPSY; KIDNEY DISEASE; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; PROTEINURIA; PRURITUS; SUBTOTAL THYROIDECTOMY; TACHYCARDIA; URINALYSIS; WEIGHT REDUCTION;

ADOLESCENT; ANTITHYROID AGENTS; AUTOANTIBODIES; FEMALE; GRAVES DISEASE; HEPATITIS, AUTOIMMUNE; HUMANS; NEPHRITIS; PEROXIDASE; PROPYLTHIOURACIL; TREATMENT OUTCOME;

EID: 3242773744     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.516     Document Type: Article

References (14)

1. Cooper DS. Antithyroid drugs. N Engl J Med 311: 1353-1362, 1984.
2. Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 102: 1595-1596, 1992.
3. Falk RJ, Jenette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657, 1988.
4. Zauli D, Ghetti S, Grassi A, et al. Anti-neutrophil cytoplasmic autoantibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25: 1105-1107, 1997.
5. Orth T, Gerken G, Kellner R, Meyer zum Buschenfelde KH, Mayet WJ. Actin is a target antigen of anti-neutrophil cytoplasmic autoantibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol 26: 37-47, 1997.
6. Kim HJ, Kim BH, Han YS, et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol 96: 165-169, 2001.
7. 14C] propylthiouracil in human polymorphonuclear leukocytes. Biochem Pharmacol 28: 2289-2296, 1979.
8. Lee E, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K. Inactivation of peroxidase of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Pharmacol 37: 2151-2153, 1988.
9. Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of antineutrophil cytoplastic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113: 656-663, 1990.
10. Tanwani LK, Lohano V, Broadstnonoe VL, Mokshagundam SP. Minimal change nephropathy and Graves' disease: Report of a case and review of the literature. Endocr Pract 8: 40-43, 2002.
11. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocr J 49: 329-334, 2002.
12. Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody in childhood onset Graves' disease treatment with propylthiouracil. J Clin Endocrinol Metab 85: 4270-4273, 2000.
13. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108: 1159-1166, 1995.
14. Inoue K, Okajima T, Tanaka E, et al. A case of Graves' disease associated with autoimmune hepatitis and mixed connective tissue disease. Endocr J 46: 173-177, 1999.